Loading...
Chemical structure of TAS0612

GC73727

TAS0612

Also known as 4-[4-[3-[2-(tert-butylamino)ethylamino]-6-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]-2-pyridinyl]piperidin-1-yl]-5,5-dimethyl-7H-pyrrolo[2,3-d]pyrimidin-6-one

TAS0612 is an orally novel inhibitor of RSK、AKT and S6K

ChemicalCAS2148902-58-1MW573.61FormulaC27H34F3N9O2
CAS number
2148902-58-1
Molecular weight
573.61
Formula
C27H34F3N9O2
Solubility
DMSO ： 50 mg/mL (87·17 mM; ultrasonic and warming and heat to 60°C)
InChIKey
JXSXWPCGHMFVGR-UHFFFAOYSA-N
Catalogue number
GC73727
Brand
GLPBIO
Computed properties PubChem CID 132162214 · XLogP 3 · TPSA 134 Ų · H-bond donors 3
XLogP
3
TPSA
134 Ų
H-bond donors
3
H-bond acceptors
13
Rotatable bonds
8
Heavy atoms
41

SMILES CC1(C2=C(NC1=O)N=CN=C2N3CCC(CC3)C4=C(C=CC(=N4)C5=NN=C(O5)C(F)(F)F)NCCNC(C)(C)C)C

Computed descriptors from PubChem (CID 132162214), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.